Abstract
Before I review the present status of oral zinc supplements in rheumatoid arthritis, I believe it is appropriate to briefly describe this disease and the accepted approach used in evaluating new therapeutic agents. Rheumatoid arthritis is a chronic inflammatory disease primarily affecting the joints but often also attacking additional organ systems. The illness is best recognized by a symmetrical pattern of inflamed peripheral joints which ultimately may become deformed and destroyed. Because the disease characteristically fluctuates, it is not possible to distinguish between spontaneous remissions and those induced by therapy in individual patients. Because the etiology is unknown, all therapeutic agents are empirical and suppressive rather than curative in nature.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
P.A. Simkin, Lancet, II, 539 (1976).
S.N. Desai, Personal communication,
C.J. Menkes, Ch. Job, F. Delbarre, Nouv. Presse Med., 7, 760 (1978).
Ch. Job, C.J. Menkes, A. De Gery, H. Brouilhet, and F. Delbarre, in “Histidine II; Laboratory and Clinical Aspects - Therapeutic Use of Histidine and Zinc, G Partsch, and S. Batsford, Eds,, George Thieme Verlag, Stuttgart, 1980, p. 71 ff.
O.J. Clemmensen, J. Siggaard-Andersen, A.M. Worm, D. Stahl, F. Frost and I. Bloch, Br. J. Dermatol., 100, 411 (1980).
R.C. Mattingly and A.G Mowat (Presentation at 15th International Congress of Rheumatology, Paris, June, 1981 ).
A.C. Kennedy, R.G. Bessent, P. Davis and P.M.G. Reynolds, Br. J. Nutr., 40, 115 (1978).
W. Niedermeier and J.H. Griggs, J. Chron. Dis., 23, 527 (1971).
J.R.J.Sorenson, Inorg. Perspectives Biol. Med., 2, 1 (1978).
D.M. Grennan, J.M.L. Knudson, M.J. MacKinnon, D.B. Myers, and D.G. Palmer, NZ Med. J., 21, 47 (1980).
Z. Balogh, A.F. El-Ghobarey, G.S. Fell, D.H. Brown, J. Dunlop, and W.C. Dick, Ann. Rheum. Dis., 39, 329 (1980)
P.A. Simkin, Agents Actions, 8, 587 (1981).
R.A. Bonebrake, J.T. McCall, G.G. Hunder, and H.F. Polley, Mayo Clin. Proc., 47, 746 (1972).
U. Ambanelli, G.F. Ferraccioli, P. Bernardi, and G. Serventi, J. Rheumatol., 5. 477 (1978).
A.C. Kennedy, G.S. Fell, P.J. Rooney, W.H. Stevens, W.C. Dick, and W.W. Buchanan, Scand. J. Rheumatol., 4, 243 (1975).
C. Mery, F. Delrieu, R. Ghozlan, L. Saporta, F. Simon, B. Amor, C.J. Menkes and F. Delbarre, Scand. J. Rheumatol., 5, 241 (1976).
J. Duchateau, G. Delepesse, R. Vrijens, and H. Collet, Am. J. Med., 70. 1001 (1981).
A.C. Kennedy, R.G. Bessent, and P.M.G. Reynolds, J. Rheumatol., 7, 639 (1980).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 The Humana Press Inc.
About this chapter
Cite this chapter
Simkin, P.A. (1982). Treatment of Rheumatoid Arthritis With Zinc Sulfate. In: Sorenson, J.R.J. (eds) Inflammatory Diseases and Copper. Experimental Biology and Medicine, vol 2. Humana Press. https://doi.org/10.1007/978-1-4612-5829-2_43
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5829-2_43
Publisher Name: Humana Press
Print ISBN: 978-1-4612-5831-5
Online ISBN: 978-1-4612-5829-2
eBook Packages: Springer Book Archive